Skip to main content
[Preprint]. 2023 Oct 19:2023.10.16.562552. [Version 1] doi: 10.1101/2023.10.16.562552

Figure 3. Comparison of the variation in temperature observed for the conformational equilibria of A2AAR[A289CTET] in three different membrane mimetics.

Figure 3.

(A and B) Variable temperature 19F-NMR spectra of A2AAR[A289CTET] reconstituted in DDM-CHS micelles in complex with the (A) agonist NECA and (B) partial agonist LUF5834. Other figure presentation details are same as in Figures 1 and 2.

(C) Variable temperature 19F-NMR spectra of A2AAR[A289CTET] in complex with the agonist NECA reconstituted in LMNG-CHS micelles. Other figure presentation details are same as in Figures 1 and 2.

(D) Variable temperature 19F-NMR spectra of A2AAR[A289CTET] in complex with the agonist NECA reconstituted in POPE:POPS (70:30 molar ratio). Other figure presentation details are same as in Figures 1 and 2.

(E – H) Relative populations of each state over the range of studied temperatures determined from the fitted data shown in A – D represented in a bar chart format for A2AAR reconstituted in DDM-CHS micelles, in complex with the (E) agonist NECA and (F) partial agonist LUF5834, and A2AAR in complex with the agonist NECA reconstituted in (G) LMNG-CHS micelles and (H) lipid nanodiscs containing POPE:POPS (70:30 molar ratio).

See also Figures S1 - S4 and Table S1.